AzTrials
AzTrials

Glass Ionomer CementPhase 4NCT03034837

Effectiveness and Economic Evaluation of Glass Ionomer Material Using as Dental Sealant

A Phase 4 study testing resin sealant and ART sealant in people with Glass Ionomer Cement and Cost-effectiveness, run by Zhengzhou University at 2 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Eruption of the first permanent molar is the earliest in our oral cavity, leading to a high occurrence of dental caries in its pits and fissures. Early prevention of pit and fissure caries in this tooth is therefore of great importance for the preservation of a healthy dentition in one's life long time. Read more about this study

Who is it for?
Ages 7 to 10 yearsHealthy volunteers can take part
What is being tested?
resin sealant and ART sealant
Could I receive a placebo?
No, everyone receives an active treatment
How many people
329 participants
Where
2 sitesChina
Study dates
Jan 2016to Jun 2018
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • generally healthy grade 1-2 school children
  • with written parental consent
  • with at least 1 sound and fully erupted permanent first molar

Who cannot join

  • Can not cooperate with the treatment
  • Can not obtain the child's parental consent

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • Jianxinjie Primary School

    Zhengzhou, Henan, 450000

  • Ruhelu Primary School

    Zhengzhou, Henan, 450000

Other trials in China

About this study

Official title: Economic Evaluation of ART Sealant in Preventing Pit and Fissure Caries in Permanent First Molars in an Asia Population

Eruption of the first permanent molar is the earliest in our oral cavity, leading to a high occurrence of dental caries in its pits and fissures. Early prevention of pit and fissure caries in this tooth is therefore of great importance for the preservation of a healthy dentition in one's life long time.

It has been shown that sealing the occlusal surface with pit and fissure sealant is a highly effective method to prevent pit and fissure caries. It has also been shown that the performance of sealing pits and fissures by glass ionomer materia l (the high viscosity, classification type 2 GIC material) using finger press method used in the atraumatic restoration method is as significant as that of using the traditional resin sealant material and technique.

The purpose of this study is to evaluate the long-term cost-effectiveness performance of the two sealing materials in the prevention of pits and fissures caries in young permanent molars of schoolchildren in a dental public health program to be held in primary schools. The findings will provide valuable information for decision making on the election of proper material and method for use in dental public program, especially for child population in the rural or social-economically deprived areas.

Read the detailed description

Primary school children will be recruited and cluster randomized into three groups. Baseline dental check-up will be conducted to all the recruited children and dental status will be recorded. Placement of resin sealant or sealant using the glass ionomer material to the eligible permanent first molars or providing of oral health education will be interventions to the three groups respecively according to the group allocation. All the interventions will be provided only once in this study, and the children will be followed for at least 24 months at an six month interval to motor the dental caries of the included permanent first molars. Cost-effectiveness of placement of resin sealant and glass ionomer sealant will be evaluated and reported.

Being tested
resin sealant, ART sealant
Medical subject headings
Van der Woude syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • resin sealantDrug

    Also called SDI conseal f

    Sealing the occlusal surface of the included molars using the market product of SDI conseal f once.

  • ART sealantDrug

    Also called GIC sealant, 3M ESPE KetacTM Molar Easymix" glass ionomer cement

    Sealing the occlusal surface of the included molars using the market product of 3M ESPE KetacTM Molar Easymix" glass ionomer cement once.

Study groups in NCT03034837
Study groupRoleWhat they receive
Resin sealantActive comparatorSealing pit and fissures of the included permanent first molars using "SDI conseal f" resin sealant material once at the baseline of the study.
Receives: Drug: resin sealant
ART sealantExperimentalSealing pit and fissures of the included permanent first molars using "3M ESPE KetacTM Molar Easymix" glass ionomer cement material once at the baseline of the study.
Receives: Drug: ART sealant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cost-effectiveness of sealing

    the incrental cost-effectiveness ratio of different sealing material used in this study in preventing pit and fissure caries in the permanent molars.

    Measured: 24-month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2017 (estimated)
  2. Study startJan 2016
  3. Primary completionJun 2018
  4. Study completionJun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
329 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03034837
Sponsor's protocol ID
201503121
Status last verified
Jul 2019
First submitted
23 Jan 2017
Last updated
8 Jul 2019
Results posted
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing resin sealant and ART sealant in people with Glass Ionomer Cement and Cost-effectiveness, run by Zhengzhou University at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cost-effectiveness of sealing (time frame: 24-month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in